Gabrielsen Comments on Trump Administration’s Imposition of New Limits on ‘Guidance Documents’

10 February 2018 The New York Times News
Associate Lindsey Gabrielsen is quoted in a New York Times article, “Administration Imposes Sweeping Limits on Federal Actions Against Companies,” about the ramifications of the Justice Department’s adoption of new limits on the use of ‘guidance documents” by federal agencies.

In view of the new policy, Gabrielsen said, the government “will face serious hurdles” in enforcement actions based on violations of health care guidance documents.

Gabrielsen’s comments to the New York Times were also republished in EsquireFierceHealthcare and MSN.

Related Services


30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream